First and currently only biological targeting P-selectin.
Also indciated to control bleeding and perioperative management.
Black box warns of increased risk of blood clots and death.
Higher-dose tofacitinib linked to greater risk of pulmonary embolism in RA patients.
What you need to know about the von Willebrand factor (vWF)-directed antibody fragment.
A study found that treating patients with rivaroxaban for 45 days after hospital discharge reducedthe rate of nonfatal blood clots, but had no effect on fatal blood clots.